Item 5. Market for Registrant’s Common Equity
ITEM 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market Information
The Company's Common Stock is listed for trading on the Global Select Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) under the symbol “OSUR”. On February 23, 2025, there were 241 holders of record and approximately 19,647 holders in street name of the Company's Common Stock, and the closing price of its Common Stock was $2.75 per share.
Dividends
The Company has never paid any cash dividends and its Board of Directors does not anticipate paying cash dividends in the foreseeable future. The Company intends to retain any future earnings to provide funds for the operation and expansion of its business.
Purchases of Equity Security by the Issuer and Affiliated Purchasers
Period Total number of
shares purchased Average price
paid per Share Total number of
shares purchased
as part of publicly
announced plans
or programs Maximum number (or
approximate dollar value)
of shares that may yet be
repurchased under the plans
or programs (1)
October 1, 2025 - October 31, 2025 551,044 (2) 2.90 531,201 $28,459,997
November 1, 2025 - November 30, 2025 144,162 2.45 144,162 $28,106,600
December 1, 2025 - December 31, 2025 1,262,230 2.49 1,262,230 $24,960,000
1,957,436 1,937,593
(1) In March 2025, the Company's board of directors authorized a stock repurchase program (the “Repurchase Program”) effective March 21, 2025, whereby the Company may purchase up to $40.0 million in shares of its common stock over a period of up to two years. The amount and timing of share repurchases under the Repurchase Program may be carried out at the discretion of management through various methods in compliance with applicable state and federal securities laws, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act, in accordance with applicable securities laws and regulations.
(2) Includes shares retired to satisfy minimum tax withholdings, in connection with the vesting of restricted and performance shares, pursuant to the OraSure Technologies Inc. Stock Award Plan.
Performance Graph
The performance graph set forth below shall not be deemed “soliciting material” or “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that Section. This graph will not be deemed “incorporated by reference” into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether such filing occurs before or after the date hereof, regardless of any general incorporation language in such filing .
The following graph compares the cumulative total returns to investors in the Company’s Common Stock, the Nasdaq Composite Index, and the Nasdaq Health Care Index for the period from December 31, 2020 through December 31, 2025. The graph assumes that $100 was invested on December 31, 2020 in the Company’s Common Stock and in each of the above-mentioned indices, and that all dividends, if any, were reinvested.
The Nasdaq Composite Index was chosen because it is a broad index of companies whose equity securities are traded on Nasdaq. The Nasdaq Health Care Index was chosen as it includes companies relevant to the Company's current business, it utilizes this index as a benchmark for compensation decisions, and many healthcare investors look to this index as an appropriate benchmark for stock performance. Stockholders are cautioned that the graph shows the returns to investors only as of the dates noted and may not be representative of the returns for any other past or future period.
Table of Contents
Fiscal Year Ending December 31,
2020 2021 2022 2023 2024 2025
OraSure Technologies, Inc. 100.00 82.10 45.54 77.47 34.10 22.86
NASDAQ Composite 100.00 122.18 82.43 119.22 154.48 187.14
NASDAQ Health Care 100.00 89.96 67.65 68.20 66.46 81.27
Securities Authorized for Issuance Under Equity Compensation Plans
For certain information concerning securities authorized for issuance under the Company's equity compensation plan, see Item 12, “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.”
Item 6. Reserved
Not Applicable
Table of Contents